Moderna (MRNA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
What happened Shares of Moderna (NASDAQ: MRNA) were jumping 2.5% as of 11 a.m. ET on Tuesday after rising as much as 5.6% earlier in the day. The gain especially stood out with the overall market falling due to worries about a potential recession.
Pfizer, BioNTec and Moderna are part of Zacks Analyst top Blog.